A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.

HomeNews & ResourcesSpotlightSpotlight on… Philip Dunne Director of Operations...
image

Philip joined Bionical Emas in January 2021 as Director of Operations (Europe). He brings with him over 30 years’ supply chain experience covering pharma, medical devices and within the clinical trial sector.

He has extensive knowledge in the global supply of clinical trial drugs and ancillaries, with a strong understanding of ambient and cold chain distribution requirements. His experience in secondary packaging and labelling of trial materials, covers both set up and day to day operations.

Philip is a keen runner and has recently achieved a personal sporting accolade after completing his 100th marathon in Lilliput.

He is currently overseeing the design and build of the Bionical Emas European Logistics Hub in Ireland. The unit is situated in Kilbeggan Co. Westmeath, one hour outside of Dublin.

The state-of-the-art temperature-controlled facility will be used to store, distribute, and label medicinal products for use around the world. With a unit size of 7000sqft, the premises will be made up of an office and logistics centre, large ambient storage, and cold chain areas. There will also be three secondary packaging and labelling suites at controlled temperature of 15-25⁰C and two suites at 2-8⁰C.

This Distribution Centre will provide a major expansion to the existing logistics and storage capabilities currently in place to support the Bionical Emas Clinical Trial Supply and Early Access Program teams, further enhancing our global service offerings and enabling us to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.

To find out more about Bionical Emas or to contact Philip directly, please email philip.dunne@bionical-emas.com.

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.